Thousands of Air Force personnel set to miss next week's COVID-19 vaccination deadline

The deadline for active-duty Air Force personnel to get fully vaccinated against COVID-19 is Tuesday, and officials estimate that up to 12,000 airmen won't hit that target, officials told The Washington Post.
The Air Force is the third-largest military service, with 324,000 active-duty airmen, and more than 94 percent are fully vaccinated and 1.8 percent partially vaccinated. Of those who have not yet received at least one dose of a COVID-19 vaccine, it's unclear how many are outright refusing to get vaccinated compared to those who are seeking a religious or medical exemption or are close to leaving the service.
The vaccine directive was made in August, and Air Force officials have warned that those who defy immunization orders are subject to disciplinary action, including dismissal from the service. The Pfizer and Moderna vaccines require two shots for full vaccination, with the doses given several weeks apart, so anyone who has not yet received their first shot will not be fully vaccinated by Tuesday.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
When people join the military, they are required to get several vaccines, including chickenpox and hepatitis A. Katherine L. Kuzminski, a military policy expert at the Center for a New American Security, told the Post she will be paying attention to whether there is a mass dismissal of personnel who refuse to get the COVID-19 vaccine, and if it will hit certain positions — like pilots or aircraft maintainers — harder than others. "The fact that it's a choice leading to potential loss to readiness is striking," Kuzminski said.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Thrilling must-see operas for 2025
The Week Recommends From Carmen to Peter Grimes, these are the UK's top productions
By Irenie Forshaw, The Week UK Published
-
There is a 'third state' between life and death
Under the radar Cells can develop new abilities after their source organism dies
By Devika Rao, The Week US Published
-
Is it worth getting an interest-only mortgage?
The Explainer Your monthly payments may be cheaper but the full mortgage amount will need to be paid back eventually
By Marc Shoffman, The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
How close are we to a norovirus vaccine?
Today's Big Question A new Moderna trial raises hopes of vanquishing a stomach bug that sickens millions a year
By David Faris Published